Changes for antihypertensive dual therapy fixed dose combinations


PBS implements PBAC recommendations on antihypertensive dual therapy fixed dose combinations  Changes to Pharmaceutical Benefits Scheme (PBS) restrictions have been made to allow fixed dose combinations (FDCs) for dual therapy antihypertensives to be used as a first-line treatment.  In an update posted on the PBS website, the Department of Health, Disability and Ageing, noted that the reform was

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Telehealth could help as fuel crisis bites: Naunton
Next PBS knockback ‘discriminates against a low socioeconomic, regional community’